首页 | 本学科首页   官方微博 | 高级检索  
检索        

保肝药物联合WLGy-801型肝病治疗仪治疗抗结核药物性肝损伤的疗效研究
引用本文:陈小龙,钟林春,李灿.保肝药物联合WLGy-801型肝病治疗仪治疗抗结核药物性肝损伤的疗效研究[J].河北医学,2008,14(1):70-72.
作者姓名:陈小龙  钟林春  李灿
作者单位:广东省徐闻县慢性病防治站,广东,徐闻,524100
摘    要:目的:探讨常规保肝药物联合WLGy-801型肝病治疗仪治疗抗结核药物性肝损伤的临床疗效。方法:118例初治菌阳肺结核患者随机分为观察组和对照组,均应用"2H3R3Z3E3(S3)/4H3R3"方案抗结核化疗,对照组57例予以常规保肝治疗,观察组61例在常规保肝治疗的基础上联用WLGy-801型肝病治疗仪刺激相应穴位,疗程为1个月。结果:观察组临床症状的消失及SB、ALT、AST的复常率均优于对照组,两者差异有统计学意义(P
关 键 词:抗结核药物  肝损伤  保肝药物  WLGy-801型肝病治疗仪
文章编号:1006-6233(2008)01-0070-03

The Effect of Liver Protectant Therapy Combination WLGy-801 Liver Disease Therapy Instrument in Treating Patients with Hepatic Injury of Antituberculosis Drugs
CHEN Xiao-long,ZHONG Lin-chun,LI Can.The Effect of Liver Protectant Therapy Combination WLGy-801 Liver Disease Therapy Instrument in Treating Patients with Hepatic Injury of Antituberculosis Drugs[J].Hebei Medicine,2008,14(1):70-72.
Authors:CHEN Xiao-long  ZHONG Lin-chun  LI Can
Abstract:Objective: To evaluate the effect of ordinary liver protectant combined with WLGy-801 liver disease therapy instrument in treating patients with hepatic injury of antituberculosis drugs.Method: A total of 118 initial treatment cases with pulmonary tuberculosis were randomly divided into control group and observation group,which all received antituberculosis therapy of 2H3R3Z3E3(S3)/4H3R3.The control group(n=57) received ordinary liver protectant therapy,and observation group(n=61)received combination therapy of liver protectant therapy and WLGy-801 liver disease therapy instrument.The course of treatment was one month.Result: The two groups are significantly different in disappearance of clinical symptom,and recover of SB,ALT,AST(P<0.05).Conclusion: Effect of combination therapy was obviously,safety,and was worth utilizing widely in clinic.
Keywords:Antituberculosis drugs  Hepatic injury  Liver protectant  WLGy-801 liver disease therapy instrument
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号